Publication | Closed Access
Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma
11
Citations
24
References
2017
Year
Hematological MalignancyOncologyHematologyMyeloid NeoplasiaMedicineRadiation OncologyRelapsed/refractory Multiple MyelomaHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1